Skip to main content

Table 1 Liver function tests of rats under MSG-induced obesity and probiotic correction

From: Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention

Parameters

Control rats (n = 10)

MSG-induced obesity (n = 10)

B. animalis VKL (n = 10)

B. animalis VKB (n = 10)

L. casei IMVB-7280 (n = 10)

Poliprobiotics (n = 10)

Symbiter (n = 10)

Total bilirubin, umol/l

12.9 ± 0.73

12.6 ± 0.58

13.6 ± 0.68

12.5 ± 0.3

13.3 ± 0.63

12.4 ± 0.47

13.4 ± 0.63

Indirect bilirubin, umol/l

8.3 ± 0.55

8.2 ± 0.35

8.6 ± 0.47

8.2 ± 0.29

8.5 ± 0.5

8.3 ± 0.33

8.3 ± 0.53

Direct bilirubin, mmol/l

4.6 ± 0.33

4.4 ± 0.3

5.0 ± 0.29

4.3 ± 0.26

4.8 ± 0.29

4.1 ± 0.27

5.1 ± 0.23

ALT, mkkat/l

0.231 ± 0.011

0.243 ± 0.015

0.230 ± 0.013

0.209 ± 0.010

0.221 ± 0.008

0.211 ± 0.014

0.212 ± 0.007

AST, mkkat/l

0.386 ± 0.007

0.397 ± 0.011

0.396 ± 0.015

0.382 ± 0.011

0.389 ± 0.014

0.373 ± 0.016

0.381 ± 0.018

  1. Data are presented as the M ± SEM. One-way ANOVA or Kruskall-Wallis test were performed for data analysis. All differences were not significant (p > 0.05)